iGEM olive oil fix

Some of you may have read a recent New Yorker linkurl:expose ;http://www.newyorker.com/reporting/2007/08/13/070813fa_fact_mueller?currentPage=1about adulterated olive oil -- in my family of cooks, it caused quite a panic. Well, one of the iGEM teams just presented a solution, and appropriately, it's the team from Naples, Italy. The problem, they say, is that currently all the quality control methods for olive oil are done by large expensive machines. Technically, for an olive oil to be classif

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Some of you may have read a recent New Yorker linkurl:expose ;http://www.newyorker.com/reporting/2007/08/13/070813fa_fact_mueller?currentPage=1about adulterated olive oil -- in my family of cooks, it caused quite a panic. Well, one of the iGEM teams just presented a solution, and appropriately, it's the team from Naples, Italy. The problem, they say, is that currently all the quality control methods for olive oil are done by large expensive machines. Technically, for an olive oil to be classified extra virgin, it must have an oleic acid level below 0.8%. Ordinary olive oil must stay below 3.3%, and anything above that is just not fit for human consumption. They provide an appropriately small and cheap solution in the form of a yeast sensor for oleic acid. They built a system in which two transcription factors are differentially activated by a promoter -- one is activated by low oleic levels and one activated by high oleic levels. So far, though, they've only tested the promoter in an aqueous solution of oleic acid -- since yeast can exist in olive oil, they explained, it shouldn't be a problem, but further testing will tell.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies